Michael Perricaudet

Michael Perricaudet's AcademicInfluence.com Rankings

Michael Perricaudet

Biology

#12512

World Rank

#15993

Historical Rank

Immunology

#836

World Rank

#859

Historical Rank

biology Degrees

Download Badge

Biology

Michael Perricaudet's Degrees

PhD Immunology Stanford University
Bachelors Biology University of California, Berkeley

Similar Degrees You Can Earn

Best Online Bachelor's in Biology 2026

Why Is Michael Perricaudet Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Michael Perricaudet's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo (1999) (1166)
In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium (1992) (956)
An adenovirus vector for gene transfer into neurons and glia in the brain (1993) (729)
Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. (1991) (723)
Widespread long-term gene transfer to mouse skeletal muscles and heart. (1992) (597)
Transfer of a foreign gene into the brain using adenovirus vectors (1993) (535)
Adenovirus–mediated in vivo gene transfer and expression in normal rat liver (1992) (457)
Adenovirus vectors for gene delivery. (1999) (364)
Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. (1990) (334)
Structure of two spliced mRNAs from the transforming region of human subgroup C adenoviruses (1979) (325)
Two interferon mRNAs in human fibroblasts: in vitro translation and Escherichia coli cloning studies. (1980) (321)
Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1–deleted adenoviruses (1993) (310)
Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. (1998) (264)
A subset of ATM‐ and ATR‐dependent phosphorylation events requires the BRCA1 protein (2003) (246)
Adenovirus-mediated transfer of the thyroid sodium/iodide symporter gene into tumors for a targeted radiotherapy. (2000) (245)
Short‐Term BMP‐2 Expression Is Sufficient for In Vivo Osteochondral Differentiation of Mesenchymal Stem Cells (2004) (233)
RGD Inclusion in the Hexon Monomer Provides Adenovirus Type 5-Based Vectors with a Fiber Knob-Independent Pathway for Infection (1999) (211)
Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer. (1993) (209)
BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. (2000) (209)
A spliced Epstein‐Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome. (1988) (207)
Long–term correction of mouse dystrophic degeneration by adenovirus–mediated transfer of a minidystrophin gene (1993) (202)
Nf2 gene inactivation in arachnoidal cells is rate-limiting for meningioma development in the mouse. (2002) (194)
Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. (1992) (182)
Advances in adenoviral vectors: from genetic engineering to their biology (1997) (180)
Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses (1997) (171)
Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease (1994) (168)
Transplantation to the rat brain of human neural progenitors that were genetically modified using adenoviruses (1995) (160)
Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice (1998) (160)
Gamma-rays-induced death of human cells carrying mutations of BRCA1 or BRCA2 (1999) (160)
The gene for polypeptide IX of adenovirus type 2 and its unspliced messenger RNA (1980) (155)
Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells (1987) (151)
Receptors bound to antiprogestin form abortive complexes with hormone responsive elements (1988) (141)
Adenoviral-mediated gene transfer to renal tubular cells in vivo. (1994) (139)
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit (1996) (133)
Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa-EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA (1996) (129)
Canstatin Acts on Endothelial and Tumor Cells via Mitochondrial Damage Initiated through Interaction with αvβ3 and αvβ5 Integrins (2005) (128)
Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector. (1994) (127)
Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. (1996) (126)
A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus (1987) (123)
Recombinational construction in Escherichia coli of infectious adenoviral genomes. (1997) (121)
Adenovirus and adeno-associated virus mediated gene transfer. (1995) (121)
Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. (2000) (119)
Full-length and truncated versions of the hepatitis B virus (HBV) X protein (pX) transactivate the cmyc protooncogene at the transcriptional level. (1991) (112)
Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis. (2001) (111)
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patients. (1996) (111)
AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. (2001) (111)
Low-efficiency of percutaneous adenovirus-mediated arterial gene transfer in the atherosclerotic rabbit. (1995) (109)
The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. (1994) (102)
Evidence of Antiangiogenic and Antimetastatic Activities of the Recombinant Disintegrin Domain of Metargidin (2004) (100)
mRNAs from human adenovirus 2 early region 4 (1984) (98)
Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. (2008) (96)
Individual products of the adenovirus 12S and 13S EIa mRNAs stimulate viral EIIa and EIII expression at the transcriptional level. (1984) (94)
The constitutive expression of the immunomodulatory gp19k protein in E1-, E3- adenoviral vectors strongly reduces the host cytotoxic T cell response against the vector. (1995) (92)
Simultaneous CAR- and αV integrin-binding ablation fails to reduce Ad5 liver tropism (2003) (92)
Epstein-Barr virus mRNAs produced by alternative splicing. (1986) (91)
Construction of a defective adenovirus vector expressing the pseudorabies virus glycoprotein gp50 and its use as a live vaccine. (1990) (89)
Complete recovery of mice from a pre-established tumor by direct intratumoral delivery of an adenovirus vector harboring the murine IL-2 gene. (1995) (87)
Long-Term Radioiodine Retention and Regression of Liver Cancer after Sodium Iodide Symporter Gene Transfer in Wistar Rats (2004) (85)
Constitutive Association of BRCA1 and c-Abl and Its ATM-Dependent Disruption after Irradiation (2002) (85)
Replication-defective recombinant adenovirus expressing the Epstein-Barr virus (EBV) envelope glycoprotein gp340/220 induces protective immunity against EBV-induced lymphomas in the cottontop tamarin. (1993) (84)
The sequence of the 3' non-coding region of the hexon mRNA discloses a novel adenovirus gene (1981) (84)
In vivo adenovirus-mediated gene transfer into ocular tissues. (1994) (83)
In vitro and in vivo hepatoma cell-specific expression of a gene transferred with an adenoviral vector. (1996) (83)
A recombinant E1-deleted canine adenoviral vector capable of transduction and expression of a transgene in human-derived cells and in vivo. (1997) (81)
Expression mechanism of the hepatitis B virus (HBV) C gene and biosynthesis of HBe antigen. (1989) (80)
Adenoviral vectors as functional retrograde neuronal tracers (1994) (80)
In vitro and in vivo synthesis of the hepatitis B virus surface antigen and of the receptor for polymerized human serum albumin from recombinant human adenoviruses. (1985) (79)
Reduction of restenosis after angioplasty in an atheromatous rabbit model by suicide gene therapy. (1997) (79)
Recombinant adenoviruses as vaccines. (1995) (78)
Noradrenergic neuronal development is impaired by mutation of the proneural HASH-1 gene in congenital central hypoventilation syndrome (Ondine's curse). (2003) (78)
Structure of two adenovirus type 12 transforming polypeptides and their evolutionary implications (1980) (76)
An abinitio quantum-mechanical investigation on the rotational isomerism in amides and esters. (2009) (75)
Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. (2003) (74)
Defective and nondefective adenovirus vectors for expressing foreign genes in vitro and in vivo. (1991) (74)
Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. (2005) (70)
An Epstein-Barr virus transcription unit is at least 84 kilobases long. (1986) (69)
Radiation and inhibition of angiogenesis by canstatin synergize to induce HIF-1alpha-mediated tumor apoptotic switch. (2007) (69)
Induction of a cytolytic T‐cell response in mice with a recombinant adenovirus coding for tumor antigen P815A (1996) (69)
Lung gene therapy: in vivo adenovirus-mediated gene transfer to rhesus monkey airway epithelium. (1994) (68)
Efficient adenovirus-mediated gene transfer into human blood monocyte-derived macrophages. (1993) (67)
High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. (2007) (67)
Spliced RNA from the IR1‐U2 region of Epstein‐Barr virus: presence of an open reading frame for a repetitive polypeptide. (1984) (67)
Adenoviral Vector as a Gene Delivery System into Cultured Rat Neuronal and Glial Cells (1993) (65)
Genetic manipulations of adenovirus type 5 fiber resulting in liver tropism attenuation (2003) (64)
Transposition of the thyroid iodide uptake and organification system in nonthyroid tumor cells by adenoviral vector-mediated gene transfers. (2002) (61)
Efficient, Repeated Adenovirus-Mediated Gene Transfer in Mice Lacking both Tumor Necrosis Factor Alpha and Lymphotoxin α (1998) (60)
Adenoviral interleukin-2 gene transfer into P815 tumor cells abrogates tumorigenicity and induces antitumoral immunity in mice. (1993) (60)
Simultaneous CAR- and alpha V integrin-binding ablation fails to reduce Ad5 liver tropism. (2003) (57)
Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors (1997) (57)
The E4 transcriptional unit of Ad2: far upstream sequences are required for its transactivation by E1A. (1984) (56)
Gene therapy of rat C6 glioma using adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene: long-term follow-up by magnetic resonance imaging. (1996) (56)
Gene therapy using adenovirus vectors. (1995) (55)
Heart muscle-specific gene expression using replication defective recombinant adenovirus. (1996) (53)
High frequency of specific CD8+ T cells in the tumor and blood is associated with efficient local IL-12 gene therapy of cancer. (1999) (52)
Highly efficient adenovirus-mediated gene transfer to cardiac myocytes after single-pass coronary delivery. (2000) (50)
Systemic delivery of antiangiogenic adenovirus AdmATF induces liver resistance to metastasis and prolongs survival of mice. (1999) (49)
Suppression of angiogenesis, tumor growth, and metastasis by adenovirus-mediated gene transfer of human angiotensinogen. (2006) (49)
Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene. (1997) (48)
A novel method using baculovirus-mediated gene transfer for production of recombinant adeno-associated virus vectors. (2001) (47)
SCF ab initio molecular orbital study on the relative affinities of peptide and ester carbonyl groups for Na+ and K+ ions (1973) (47)
Lung overexpression of angiostatin aggravates pulmonary hypertension in chronically hypoxic mice. (2003) (45)
Active specific T-cell-based immunotherapy for cancer: nucleic acids, peptides, whole native proteins, recombinant viruses, with dendritic cell adjuvants or whole tumor cell-based vaccines. Principles and future prospects. (1998) (44)
In vivo adenovirus-mediated transfer of human CFTR cDNA to rhesus monkey airway epithelium: efficacy, toxicity and safety. (1994) (43)
Heart-specific targeting of beta-galactosidase by the ventricle-specific cardiac myosin light chain 2 promoter using adenovirus vectors. (1998) (41)
Predicted structure of two adenovirus tumor antigens. (1980) (39)
Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus. (1991) (39)
The use of adenovirus vectors for intracerebral grafting of transfected nervous cells. (1994) (39)
In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy (2003) (39)
Erythropoietin gene transfer and expression in adult normal mice: use of an adenovirus vector. (1994) (39)
Mapping of the gene coding for Epstein-Barr virus-determined nuclear antigen EBNA3 and its transient overexpression in a human cell line by using an adenovirus expression vector (1987) (39)
Combined effects of docetaxel and angiostatin gene therapy in prostate tumor model. (2003) (38)
Gene transfer to human fetal pulmonary tissue developed in immunodeficient SCID mice. (1994) (38)
Antitumoral Activity and Osteogenic Potential of Mesenchymal Stem Cells Expressing the Urokinase‐Type Plasminogen Antagonist Amino‐Terminal Fragment in a Murine Model of Osteolytic Tumor (2008) (38)
Hepatitis B virus (HBV) X gene expression in human cells and anti-HBx antibodies detection in chronic HBV infection. (1990) (37)
Restoration of hexosaminidase A activity in human Tay-Sachs fibroblasts via adenoviral vector-mediated gene transfer. (1996) (37)
Mechanism of adenovirus improvement of cationic liposome-mediated gene transfer. (1997) (36)
CFTR gene transfer corrects defective glycoconjugate secretion in human CF epithelial tracheal cells. (1995) (35)
Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice (2007) (33)
Defective bacteriophage lambda chromosome, potential vector for DNA fragments obtained after cleavage by bacillus amyloliquefaciens endonuclease (BamI) (1975) (33)
The E4 promoter of adenovirus type 2 contains an E1A dependent cis-acting element. (1986) (32)
LacZ gene transfer into tumor cells abrogates tumorigenicity and protects mice against the development of further tumors. (1996) (32)
Significance of anti‐HBx antibodies in hepatitis B virus infection (1991) (31)
Construction of restriction enzyme fragment libraries containing DNA from human adenovirus types 2 and 5. (1980) (31)
Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis (2002) (31)
Validation of a New Method for Quantifying In Vivo Murine Tumor Necrosis by Sonography (2004) (31)
Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway. (2005) (30)
Novel downstream elements upregulate transcription initiated from an Epstein‐Barr virus latent promoter. (1991) (30)
Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect. (2003) (29)
Different mRNAs from the transforming region of highly oncogenic and non-oncogenic human adenoviruses (1982) (28)
Transcriptional activation by the E1A regions of adenovirus types 40 and 41. (1987) (28)
Adenoviral-mediated TGF-beta1 inhibition in a mouse model of myelofibrosis inhibit bone marrow fibrosis development. (2007) (27)
Stable transduction of actively dividing cells via a novel adenoviral/episomal vector. (2000) (27)
Bacterial cloning of the rabbit uteroglobin structural gene. (1980) (27)
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration (2007) (27)
Reduction of brain metastases in plasminogen activator inhibitor-1-deficient mice with transgenic ocular tumors. (2008) (26)
Structure of three spliced mRNAs from region E3 of adenovirus type 2. (1983) (26)
Angiogenesis induced in muscle by a recombinant adenovirus expressing functional isoforms of basic fibroblast growth factor (1999) (25)
Gene Therapy: The Advent of Adenovirus (1994) (24)
Activation of HIV-specific ribozyme activity by self-cleavage. (1993) (24)
Bacteriophage lambda and plasmid vectors, allowing fusion of cloned genes in each of the three translational phases. (1978) (24)
16-kDa fragment of pleiotrophin acts on endothelial and breast tumor cells and inhibits tumor development (2008) (24)
Full kringles of plasminogen (aa 1–566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice (2005) (22)
Description and properties of bacteriophage lambda vectors useful for the cloning of EcoRI DNA fragments. (1978) (22)
Systemic administration of a recombinant adenovirus encoding a HSA-Angiostatin kringle 1-3 conjugate inhibits MDA-MB-231 tumor growth and metastasis in a transgenic model of spontaneous eye cancer. (2003) (21)
Canstatin gene electrotransfer combined with radiotherapy: preclinical trials for cancer treatment (2008) (21)
Adenoviral gene delivery. (1997) (20)
Polyadenylic Acid Addition Sites in the Adenovirus Type 2 Major Late Transcription Unit (1984) (20)
Adenoviral SERCA1a gene transfer to adult rat ventricular myocytes induces physiological changes in calcium handling. (2001) (20)
The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers (2006) (19)
Polyadenylic acid addition sites in the adenovirus type 2 major late transcription unit (1983) (19)
Keratinocytes as a target for gene therapy. Sustained production of erythropoietin in mice by human keratinocytes transduced with an adenoassociated virus vector. (1996) (19)
Dynamics of gene transfer to retinal pigment epithelium. (1996) (18)
Transplantation of cells genetically modified and direct intracerebral gene transfer with an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's disease. (1995) (18)
BRCA1 carries tumor suppressor activity distinct from that of p53 and p21 (2001) (18)
Excision and recombination of adenovirus DNA fragments in Escherichia coli. (1977) (17)
Adenovirus-mediated In Vivo Gene Therapy (1995) (17)
Polarity of secretion of alpha 1-antitrypsin by human respiratory epithelial cells after adenoviral transfer of a human alpha 1-antitrypsin cDNA. (1995) (17)
Differential toxicity of ganciclovir for rat neurons and astrocytes in primary culture following adenovirus-mediated transfer of the HSVtk gene (1997) (17)
Efficient delivery of angiostatin K1-5 into tumors following insertion of an NGR peptide into adenovirus capsid (2009) (16)
IL-2 gene delivery within an established murine tumor causes its regression without proliferation of preexisting antitumor-specific CTL. (1997) (16)
Antitumorigenic effects of a mutant of the heparin affin regulatory peptide on the U87 MG glioblastoma cell line (2009) (15)
In Vitro Echogenicity Characterization of Poly[lactide-coglycolide] (PLGA) Microparticles and Preliminary In Vivo Ultrasound Enhancement Study for Ultrasound Contrast Agent Application (2005) (15)
Propagation in E. coli of bacteriophage lambda with integrated fragments of adenovirus 2 DNA. (1976) (14)
The messenger RNAs from the transforming region of human adenoviruses. (1984) (14)
Anti-adenovirus humoral responses influence on the efficacy of vaccines based on epitope display on adenovirus capsid. (2011) (14)
High level of stabilized angiostatin mediated by adenovirus delivery does not impair the growth of human neuroblastoma xenografts (2003) (14)
Feasibility of adenovirus-mediated gene transfer in vivo. (1992) (14)
The soluble fragment of VE-cadherin inhibits angiogenesis by reducing endothelial cell proliferation and tube capillary formation (2010) (13)
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer (2007) (13)
Organoids direct systemic expression of erythropoietin in mice. (1995) (12)
Adenovirus mediated gene transfer in organotypic brain slices (1995) (11)
Expression from cardiomyocyte-specific promoter after adenovirus-mediated gene transfer in vitro and in vivo. (1997) (11)
Adenovirus-mediated gene transfer of a human IL-6 antagonist (1997) (11)
Adenovirus-mediated gene transfer in dog prostate: a preclinical study of a relevant model system for gene therapy of human prostatic cancer (1999) (11)
Identification of a short amino acid sequence essential for efficient nuclear targeting of the Epstein-Barr virus nuclear antigen 3A (1993) (11)
cDNA cloning and transient expression of the Epstein-Barr virus-determined nuclear antigen EBNA3B in human cells and identification of novel transcripts from its coding region (1990) (10)
Purification of RNA-DNA hybrids by exclusion chromatography. (1979) (10)
Expression of non‐signaling membrane‐anchored death receptors protects murine livers in different models of hepatitis (2006) (10)
Robust functional gene validation by adenoviral vectors: one-step Escherichia coli-Derived Recombinant Adenoviral Genome construction (2004) (10)
Expression of human alpha 1-antitrypsin using a recombinant adenovirus vector. (1990) (9)
Clustered alternative splice sites in Epstein-Barr virus RNAs. (1987) (9)
Induction of cytolytic T lymphocytes by immunization of mice with an adenovirus containing a mouse homolog of the human MAGE-A genes (2001) (9)
Adenovirus‐mediated gene transfer to the transplanted piglet heart after intracoronary injection (2003) (8)
Strategies for cancer gene therapy using adenoviral vectors (1996) (8)
Enhancement of humoral immunity to SIVenv following simultaneous inoculation of mice by three recombinant adenoviruses encoding SIVenv/poliovirus chimeras, Tat and Rev. (1997) (7)
Respective roles of TNF-α and IL-6 in the immune response-elicited by adenovirus-mediated gene transfer in mice (2007) (7)
Complete characterization of the gene coding for the Epstein-Barr virus major membrane antigen gp 220/340 and selective expression of a secreted form of gp 220. (1989) (6)
Improved efficiency of percutaneous adenoviral-mediated arterial gene transfer by pre-treatment with elastase (1996) (6)
Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses (2000) (5)
Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells (2001) (5)
Recombinant interleukin-2 pre-treatment increases anti-tumor response to paclitaxel by affecting lung P-glycoprotein expression on the Lewis lung carcinoma (2006) (5)
Regulated expression of Epstein-Barr virus nuclear antigen 3-encoding gene carried on stable episomal vectors in human cells. (1990) (5)
Adenovirus mediated gene transfer to the central nervous system. (1994) (4)
HARPΔ111-136 enhances radiation-induced apoptosis of U87MG glioblastoma by induction of the proapoptotic protein CHOP. (2010) (4)
Analysis of cloned mRNA sequences from the transforming region of adenovirus 2. (1980) (4)
A soluble truncated cadherin induces breast cancer cell apoptosis and growth inhibition (2006) (4)
Residual expression of reporter genes in constructs mimicking HIV genome organization. (1995) (3)
Using adenoviral vectors to transfer the CNTF gene into the CNS. (1995) (3)
The analysis of EBV proteins which are antigenic in vivo. (1988) (3)
P 201 Enhanced in vivo gene transfer into ocular tissues (1995) (3)
Recombinant Adenoviruses Which Express the EBV Major Membrane Antigen GP340/220 Induce Persistent EBV-Neutralizing Antibodies in Rabbits (1991) (2)
[Adenovirus, a gene therapy vector: application to lung diseases]. (1995) (2)
Expression of rubella virus cDNA encoding the E1 structural protein. (1989) (2)
Targeted adenoviral vectors (2001) (2)
Adenovirus vector-transduced hepatocytes implanted via a preformed collagen/PTFE support persist for at least 4 weeks in vivo. (1996) (2)
Improvement of Adenoviral Vectors for Human Gene Therapy (1996) (2)
Antitumor effects of Flt3L in poorly immunogenic mouse tumor models (1997) (1)
Individual products of the adenovirus 12 S and 13 S EIa mRNAs stimulate viral (1)
[Development of adenoviral vectors in gene therapy: application to gene transfer in muscles]. (1996) (1)
967. Angiotensinogen Inhibits Growth and Angiogenesis of Human Mammary Carcinoma and Prevents Pulmonary Metastasis of Murine Melanoma Cancer (2004) (1)
Integration of viral sequences into the c-myc gene in two mammary adenocarcinomas induced by polyomavirus in athymic nude mice (1995) (1)
Human recombinant adenovirus used to correct a mouse enzyme deficiency (1990) (1)
Antitumoral Activity and Osteogenic Potential of hATF-Expressing Mesenchymal Stem Cells In A Murine Model of Osteolytic Tumor. (2008) (1)
Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal unit (1996) (1)
A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer (2007) (1)
[Molecular biology of the transforming region of human type 5 adenovirus]. (1983) (1)
The identification of new transcription elements active in Epstein-Barr virus latent gene expression. (1991) (1)
The two core sequences of the adenovirus E1A inducible E4 promoter are required for the formation of a specific DNA-protein complex. (1989) (1)
The recombinant adenoviruses for gene therapy of cancers (1996) (0)
defective recombinant adenoviruses with a IVA2 inactivated gene. (1995) (0)
Process for producing recombinant viruses (1996) (0)
Cells for prodn. of recombinant adeno and adeno-associated virus (1995) (0)
Process for preparing recombinant adeno-associated viruses (AAVs), and uses (1995) (0)
Adenoviruses, which is not viable contaminating particles, their preparation and uses (1997) (0)
Adenovirus comprising a gene coding for a superoxide dismutase (1994) (0)
Adenoviral Expression of the Amyloid Precursor Protein (1995) (0)
Glial cells from a neurotrophic factor (GDNF) coding for the recombinant adenoviruses (1996) (0)
524. Adenovirus-Mediated Gene Delivery of Decoy Death Receptors Protects Mice from Hepatitis (2005) (0)
Adenoviral vectors for transferring foreign genes in the central nervous system, particularly the brain, the cells (1995) (0)
Defective adenoviruses comprising a therapeutic gene and the immunoprotective gene (1997) (0)
Identification of recombinant plasmids containing DNA sequences derived from the 3′ end of ovine thyroglobulin mRNA (1982) (0)
Repression of the viral latent promoter BC-R2 in Epstein-Barr virus negative cell lines. (1992) (0)
[Construction of derivatives of bacteriophage lambdaplac5 vectors permitting the placement of foreign genes under the control of lactose operon promotor of Escherichia Coli (proceedings)]. (1978) (0)
Adenoviruses Recombinant, sodium iodide symporter coding (2000) (0)
Recombinant viruses and their use in gene therapy for the treatment of eye diseases (1995) (0)
For glutamate decarboxylase activity-encoding virus recombining (1995) (0)
useful combination drug for transfection and in vivo expression of exogenous (1995) (0)
A process for preparing adeno-associated virus (AAV) recombinant and uses. (1994) (0)
recombinant viruses, preparation and use in gene therapy (1994) (0)
The glutamate decarboxylase activity (GAD) activity encoded by the recombinant viruses technical (1996) (0)
Treatment Method of restenosis by gene therapy (1994) (0)
Irish Association for Cancer Research (1995) (0)
Adenovirus-mediated transfer of a recombinant human ai-antitrypsin cDNA to human endothelial cells (0)
In vivo antiangiogenic gene therapy mediated by electrotransfer in a transgenic mouse model of intraocular tumor with metastases. (2004) (0)
Strategies for the improvement of adenoviral vectors to increase the length of exogene expression (1995) (0)
Methods for producing recombinant adeno-associated viruses (AAV), and the use thereof (1995) (0)
Method of preparing recombinant adeno-associated virus (AAV) and their uses. (1995) (0)
Transcriptional Regulation of an Epstein-Barr Virus Nuclear Antigen Gene Promoter (1991) (0)
Methods and compositions for the production of viral particles (1998) (0)
Adenoviral vectors defective and use in gene therapy. (1994) (0)
An EBV RNA with A Repetitive Spliced Structure (1985) (0)
Anti-angiogenic approaches for cancer gene therapy (2001) (0)
IL-2 gene transfer into tumor cells using an adenovirus vector abrogates tumorigenicity and induces antitumoral immunity in mice (1994) (0)
For GDNF coding recombinant adenoviruses (1995) (0)
Gene transfer into mesothelioma cells using adenovirus vector (1996) (0)
recombinant virus production Method (1996) (0)
Restenosiksen gene therapy where an adenoviral vector is used for (1996) (0)
Mammary Tumor Growth and Angiogenesis Tissue Inhibitor of Metalloproteinase-2 : Effect on in Vivo Down-Regulation of Vascular Endothelial Growth Factor by Updated (2001) (0)
Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system, especially in the brain (1993) (0)
Rekombinatie virus, their production and their use in gene therapy (1995) (0)
Adenoviruses (Part II): Improvement of Adenoviral Vectors for Human Gene Therapy: E1 and E4 Deleted Recombinant Adenoviruses (1997) (0)
4113 Adenoviral gene transfer into human endothelial corneal cells of corneal grafts ex vivo (1995) (0)
Defective recombinant adenovirus for gene therapy of tumors (1994) (0)
Towards gene therapy targeting HDL (1994) (0)
Predicted structure of two adenovirus tumor antigens ( transformation / splicing / DNA sequence ) (0)
Adenoviral vectors of animal origin and their use in gene therapy (1994) (0)
Incorporation of a targeting ligand into adenovirus capsid as a mean of delivery of anti-angiogenic factors into tumors (2008) (0)
Third-generation adenovectors for gene therapy. (1995) (0)
Stabilized-Angiostatin Gene Transfer: Inhibition of Metastasis Development in an Eye-tumor Transgenic Mouse Model (2003) (0)
Cytokine expremierender defective recombinant adenovirus in use in anti-tumor treatment (1993) (0)
Recombinant adenoviral vectors for gene therapy of human tumors. (1997) (0)
Viruskombinantteja and their use in gene therapy (1995) (0)
Nucleic Acids Research (2011) (0)
Anti-tumoral effects following Ad-mediated delivery of angiogenesis inhibitors (1999) (0)
Composition for the production of therapeutics in vivo. (1993) (0)
Recombinant adenovirenvektoren for gene therapy of human cancers (1997) (0)
TARGETING GENE THERAPY TO PROSTATE CANCER (2018) (0)
recombinant viruses, to their preparation and their therapeutic use. (1994) (0)
Efficient Local IL-12 Gene Therapy of Cancer the Tumor and Blood Is Associated with T Cells in + High Frequency of Specific CD8 (0)
Adenoviral vectors. (1995) (0)
285. Evidence of Antiangiogenic and Antimetastatic Activities of the Recombinant Disintegrin Domain of Metargidin (2004) (0)
Defective Adenovirus vectors and their use in gene therapy (1994) (0)
Adenovirus devoid of viable contaminating particles, preparation and use (1994) (0)
[Gene transfer with a therapeutic purpose in the central nervous system]. (1993) (0)
recombinant viral vectors for expression in a muscle cell. (1992) (0)
The cells produce the recombinant adenoviruses (1997) (0)
Process for the preparation of animal adenoviral gene therapy vectors (1995) (0)
Dynamic assessment of antiangiogenic therapy by monitoring both tumoral vascularization and tissue degeneration (2007) (0)
398 Adenoviral expression of the human amyloid precursor protein in rat cultured neurons (1996) (0)
Recombinant adenoviral for gene therapy of human tumors (1997) (0)